Literature DB >> 22053600

Cutaneous adverse reactions to sulfonamide antibiotics.

Weeranut Chantachaeng1, Leena Chularojanamontri, Kanokvalai Kulthanan, Kowit Jongjarearnprasert, Nuruemon Dhana.   

Abstract

BACKGROUND: Sulfonamides are divided into two main groups which are sulfonamide antibiotics and sulfonamide non-antibiotics. The wide use of sulfonamide antibiotics leads to increasing incidence of sulfonamide cutaneous reactions.
OBJECTIVE: The purpose of this study is to explore the cutaneous manifestations induced by sulfonamide antibiotics in a large number of Thai patients, including human immunodeficiency virus (HIV) and non-HIV infected individuals. The second purpose is to determine the risk factors for development of sulfonamide cutaneous reactions.
METHODS: We retrospectively studied 191 patients with sulfonamide antibiotics cutaneous reactions attending the adverse drug reaction center, Siriraj Hospital, Bangkok between 2006 and 2010.
RESULTS: Majority of the patients was female (59.7%).Maculopapular rash was the most common cutaneous manifestation (37.7%) followed by fixed drug eruption (22%), angioedema with or without urticaria (12.6%) and urticaria alone (12%). Among those with known HIV serology, maculopapular eruption occurred more frequently in the HIV positive group while fixed drug eruption occurred more frequently in HIV-negative group.
CONCLUSION: From our study, there were no significant determination factors to develop serious drug reactions. However, the HIV-positive status and lower level of CD4 count had a tendency to increase risk of developing serious cutaneous reactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22053600

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

Authors:  James C Sacco; Mahmoud Abouraya; Alison Motsinger-Reif; Steven H Yale; Catherine A McCarty; Lauren A Trepanier
Journal:  Pharmacogenet Genomics       Date:  2012-10       Impact factor: 2.089

2.  Toxic epidermal necrolysis induced by Lansoprazole: pharmacologic considerations.

Authors:  Ciro Martins Gomes
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

3.  Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China.

Authors:  Yu-Ye Li; Yong-Mei Jin; Li-Ping He; Jin-Song Bai; Jun Liu; Min Yu; Jian-Hua Chen; Jing Wen; Yi-Qun Kuang
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

4.  Dermatological conditions associated with HIV medication in a cohort of Greek patients initiating antiretroviral therapy: 1988-2013.

Authors:  Iliana Alexoudi; Alexandra Katsarou; Vassileios Paparizos; Konstantino Oikonomou; Sofia Kourkounti; Georgia Augerinou; Christina Antoniou
Journal:  J Virus Erad       Date:  2018-01-01

5.  Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.

Authors:  Yat Yee Wong; Brian Johnson; Thomas C Friedrich; Lauren A Trepanier
Journal:  Pharmacol Res Perspect       Date:  2017-04-26

6.  A practical management of children with antibiotic allergy.

Authors:  Elisabetta Calamelli; Carlo Caffarelli; Fabrizio Franceschini; Francesca Saretta; Fabio Cardinale; Roberto Bernardini; Lucia Liotti; Francesca Mori; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau
Journal:  Acta Biomed       Date:  2019-01-28

Review 7.  Sulfonamide Hypersensitivity.

Authors:  Timothy G Chow; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-01       Impact factor: 8.667

Review 8.  Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.

Authors:  Evy Yunihastuti; Alvina Widhani; Teguh Harjono Karjadi
Journal:  Asia Pac Allergy       Date:  2014-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.